Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000861482 | SCV001001809 | benign | Oculofaciocardiodental syndrome | 2024-01-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004019669 | SCV005036872 | benign | Inborn genetic diseases | 2024-02-26 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ITMI | RCV000120213 | SCV000084359 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Laboratory of Diagnostic Genome Analysis, |
RCV001573019 | SCV001798286 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000120213 | SCV001952857 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000120213 | SCV001974419 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001573019 | SCV001978762 | likely benign | not provided | no assertion criteria provided | clinical testing |